Navigation Links
Burnham researchers present at 100th AACR Meeting
Date:4/17/2009

LA JOLLA, Calif., April 17, 2009 -- Burnham Institute for Medical Research (Burnham) is pleased to announce that five of its postdoctoral fellows will present seven papers on their data at the American Association for Cancer Research (AACR) 100th Annual Meeting 2009. In addition, John C. Reed, M.D., Ph.D., Burnham President and CEO, Professor and Donald Bren Presidential Chair, will chair a panel on Apoptosis-based Strategies for Cancer Therapy, where he will also present his own research.

This year's meeting, being held in Denver from April 18 to 22, will highlight the best cancer science and medicine from institutions all over the world. In addition to Dr. Reed, Burnham researchers presenting at the AACR meeting include:

  • Lilach Agemy, Ph.D., who will present Nanoparticle-induced Vascular Blockade in Prostate Cancer.
  • Jason Garrison, Ph.D., who will discuss ARTS and Siah Collaborate in a Novel Pathway for XIAP Degradation
  • Shi Ranxin, Ph.D., who will present two papers: Cyclosporin A Sensitizes Cancer Cells to Death Receptor-Mediated Apoptosis and Chemical Biology Strategy Reveals Pathway-Selective Inhibitor of NFκB Activation Induced by Protein Kinase C and Antigen Receptors.
  • Changming Fang, Ph.D., who will also present two papers: Ileal Bile Acid Binding Protein Mediates the Chemopreventative Effect of Ursodeoxycholic Acid by Activating Nuclear Receptor FXRα in Colorectal Cancer and Genetic Deletion of FXRα Promotes Colon Tumorigenesis in ApcMin/+ Mice
  • Adam Richardson, Ph.D., will present The Role of Pentose Phosphate Pathway in the Warburg Effect.


'/>"/>

Contact: Josh Baxt
jbaxt@burnham.org
858-795-5236
Burnham Institute
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. The Burnham Buzz, February 2009
2. Burnham researchers discover on switch for cell death signaling mechanism
3. The Burnham buzz
4. Burnham researchers turn cancer friend into cancer foe
5. Burnham researcher awarded $8 million grant
6. Yale researchers uncover secrets of salmonellas stealth attack
7. Singapore researchers first to transform carbon dioxide into methanol
8. Researchers identify specific lung cancer susceptibility gene
9. CSHL researchers explain process by which cells hide potentially dangerous DNA segments
10. Stem cell therapy makes cloudy corneas clear, according to Pitt researchers
11. Biomedical researchers invited to design experiments for the International Space Station

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...Whitehead researchers have developed a new type of...ic genes and proteins used by pathogens, according...ll cultures genes are present in two copies: one i...Gene inactivation by mutation is therefore ineffic...ond copy usually remains active and takes over. ,...
(Date:11/25/2009)...fornia Institute of Technology (Caltech) have unco...r in the fruit fly, Drosophila melanogaster . , ...tionship between the neurotransmitter dopamine and...are described in the December issue of the journal...y about 20,000 neurons and has long been considere...
(Date:11/25/2009)...officers and ambulance workers faced a terrifying ...hey battled to save people from the collapsing Twi...d evacuated as many people as they could in an are...making their jobs even harder was the problem of p...elatives jammed mobile networks with calls and the...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Magic box for mission impossible 2Magic box for mission impossible 3Green tea may affect prostate cancer progression 8918 1Green tea may affect prostate cancer progression 8918 2Green tea may affect prostate cancer progression 8918 3Green Tea Component May Slow Prostate Cancer 49467 1Green Tea Component May Slow Prostate Cancer 49467 2Turkish Ministry of Health Purchases Two CyberKnife 28R 29 Systems 49464 1Turkish Ministry of Health Purchases Two CyberKnife 28R 29 Systems 49464 2Turkish Ministry of Health Purchases Two CyberKnife 28R 29 Systems 49464 3
...unich (Germany) based Genomatix Software GmbH, ann...r Pharmaceuticals to provide Genomatix software an...he Genomatix tools licensed by Pfizer are designed...vel, and Pfizer scientists will use the software a...asis of how their potential drug targets may be co...
...ity of Texas M. D. Anderson Cancer Center have fo... (TG2) in ovarian cancer is associated with increa...chemotherapy and lower overall survival rates. Whe...models, cancer progression was reversed, suggestin... approach for late-stage ovarian cancer. , These...
... a special session running all day Wednesday, pres...dents involving emergency evacuations, including s...emergency response (some involving radiation). Pre...sponses. One such paper ("Assessment of Emergency ...ath of Major Natural Disasters and Technological A...
Other Biology News:TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer 2TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer 3Emergency response and nanotechnology 2
(Date:11/25/2009)...AM, ON, Nov. 25 /PRNewswire/ - Cytochroma today an... Board of Directors. Dr. Moldt will replace Mr. Ul...mpany,s Board. The number of Board members remains...sed to welcome Peter Moldt to the board and look f...nce as Cytochroma continues to make progress in be...
(Date:11/25/2009)...DIEGO, Nov. 25 Ardea Bio...at Barry D. Quart, Pharm.D., president and chief e...y 21st Annual Health Care Conference. , ,Presenta...nnual Health Care Conference,Date: Tuesday, D...Location: The New York Palace Hotel, New York, NY...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ..., ,Who: David Appia, French Ambassador for Interna...est in France Agency, , , , ,What: Ambassador App...nt pro-business initiatives adopted by France to f...landscape for innovation and development., , ,When...
(Date:11/24/2009)...RY and BLENHEIM, Ontario, Nov. 24 /PRNewswire-Firs...it is acquiring the assets of Hyland Seeds, a divi...e addition of Hyland Seeds will further expand Dow...ny anticipates the introduction of SmartStax(TM) ...nt Trait Technology in corn in 2012. The transacti...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...consumer health products company recognized as a w...Jan. 27 Origin BioMed Inc., a privately-held Cana...nced that it has been awarded as one of the Red He...g Top 100 Global Companies are chosen from winners...rth America, Europe and Asia Red Herring Top 100 C...
...vides Access to Dynamic Library of Life Science Re...OUIS, Jan. 27 Sigma-Aldrich (Nasdaq: SIAL ) and...ne powered by Ingenuity, a Web-based biological se...nt ( http://www.sigma-aldrich.com/yfg ). Based on...s, Your Favorite Gene powered by Ingenuity positio...
...monstrated greater seizure reduction and improved ... and second-generation antiepileptic drugs (AEDs) ...d European Commission approvals of Vimpat(R) , , ...t(R) (lacosamide) demonstrated significantly fewer... whose seizures were inadequately controlled despi...
Other Biology Technology:Origin BioMed Awarded Red Herring Top 100 Global Company 2Origin BioMed Awarded Red Herring Top 100 Global Company 3Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity 2Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity 3Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity 4Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy 2Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy 3Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy 4Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy 5
Mouse IL-23, Unconjugated from R&D Systems
ActivePro™ In Vitro Translation Kit from Ambion
...omer Peptide Synthesis , Containing one Phospho-A...mg will be returned to customer conjugation of pep...ance 102 days/each , Pre-immune bleed x1 /each... Test bleed (app. 5 ml) x1 /each , Production...
Donor Goat Serum from Lifeblood Medical, Inc.
Biology Products: